The Discovery of a New DrugLink to LifeSciences-Montreal.comLink to MontrealInternational.comVersion française
 
 
   

Basic Principles

 

The basic principles in the discovery and development of a drug may be summarized as follows :

Discovery

The discovery stage can last up to 6 years and experts estimate its average cost to be $US335m (2000).
The proteins produced by transcription of our genes ensure that our body’s main biological functions are carried out.

A faulty gene or protein is often what lies behind a disease.

Escherichia
Protein structure byESRF

To treat a particular disease, it is first necessary to identify the biological targets (i.e., a protein or other biopolymer) known to be involved in this disease’s etiology, and then discover the compound, or compounds, that have an effective and specific therapeutic capability and a minimum number of side-effects.

Specialists in the biological sciences and medicinal chemistry work in close collaboration throughout the entire process of drug discovery.

Development

The development of the drug can take as long as a decade, at an average cost estimated at $US467m (2000).

Once the compound, or compounds, have been chosen, they must be transformed into a drug. This process involves several series of trials on animals and humans, all intended to ensure that the drug may be administered to humans with minimum possible risk and that it is superior to, or otherwise complements, existing drugs with the same therapeutic function.

These trials are subject to the rigorous controls required by the regulatory authorities, such as Health Canada or the US Food and Drug Administration (FDA).

In addition to specialists in biology and therapeutic chemistry, the discovery of a new drug involves the collaboration of pharmaceutical R&D specialists and clinical research teams, composed of doctors, nurses and other health specialists.

 

   
 
 Back   Up     Next  

Introduction | Principles | Stages |
| Discovery | Target identificationLead identification |
Lead optimization | Preclinical trials |
| Development | Phase-1 | Phase-2 | Phase-3 | Phase-4 |
Professions | Lexicon | Useful links | French version | Site map |

©2004 All rights reserved Montreal International